Having trouble accessing articles? Reset your cache.

Alexza grants Teva U.S. rights to Adasuve

Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) jumped $0.96 (22%) to $5.31 on Wednesday after granting Teva

Read the full 149 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE